Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial

Clinical trial NCT07396480 · RECRUITING

Trial details

NCT number: NCT07396480
Sponsor: First Affiliated Hospital of Zhejiang University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Venentoclax Myeloid Malignancies Conditioning ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Acute Myeloid Leucemia Myeldysplastic Syndrome (MDS)

Start date: 2026-03-01
Primary completion: 2030-01-31
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.